Related Experiment Video
Updated: Jun 14, 2025
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Exploring the effects of vanillin and divanillin on murine osteosarcoma cells: evaluation of cellular response and
Gabriela Silva Neubern de Oliveira1, Camila Giatti Furlaneto1, Cintia Kazuko Tokuhara2
1Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru Brazil.
Abstract:
The objective of this study was to evaluate the antitumor properties of vanillin and divanillin in murine bone tumour cells. The action of the compounds on the cell viability of the normal (MC3T3-E1) and the tumour cell line (UMR-106) was evaluated. Action of the compounds in colony formation, migration, and production of reactive oxygen species (ROS) in tumour cells were evaluated along with proteomic analysis. Both compounds affected the cell viability of normal and tumour cell lines, being divanillin the more effective. For UMR-106, both compounds reduced the cell viability by less than 50%. Vanillin inhibited the migration process, and divanillin decreased ROS production (p < 0.05). The proteomic analysis showed that both compounds acted in the expression of proteins involved in tumour progression. Our results suggest that vanillin and divanillin are effective drugs against murine bone tumour cells. They can be a promising alternative for the adjuvant treatment of bone cancer.
Insights
Vanillin and divanillin show antitumor properties against murine bone tumor cells. Divanillin was more effective, reducing cell viability and reactive oxygen species (ROS) production, suggesting potential as an adjuvant bone cancer treatment.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Bone cancer poses a significant therapeutic challenge.
- Natural compounds offer potential for novel cancer treatments.
- Vanillin and divanillin are phenolic compounds with known biological activities.
Purpose of the Study:
- To investigate the antitumor effects of vanillin and divanillin on murine bone tumor cells.
- To evaluate the impact of these compounds on cell viability, migration, and reactive oxygen species (ROS) production.
- To explore the proteomic changes induced by vanillin and divanillin in bone tumor cells.
Main Methods:
- Cell viability assays on normal (MC3T3-E1) and tumor (UMR-106) cell lines.
- Colony formation, migration, and ROS production assays in UMR-106 cells.
- Proteomic analysis to identify protein expression changes.
Main Results:
- Both vanillin and divanillin reduced the viability of normal and tumor cells, with divanillin being more potent.
- Vanillin inhibited cell migration, while divanillin decreased ROS production in UMR-106 cells (p < 0.05).
- Proteomic analysis revealed that both compounds modulated proteins involved in tumor progression.
Conclusions:
- Vanillin and divanillin exhibit significant antitumor properties against murine bone tumor cells.
- Divanillin demonstrates superior efficacy in reducing cell viability and ROS production.
- These compounds represent a promising alternative for the adjuvant therapy of bone cancer.
